CALUMET INC (CLMT) Fundamental Analysis & Valuation

NASDAQ:CLMT • US1314281049

Current stock price

34.73 USD
-0.99 (-2.77%)
At close:
33.4 USD
-1.33 (-3.83%)
Pre-Market:

This CLMT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CLMT Profitability Analysis

1.1 Basic Checks

  • CLMT had negative earnings in the past year.
  • CLMT had a positive operating cash flow in the past year.
  • In the past 5 years CLMT reported 4 times negative net income.
  • In multiple years CLMT reported negative operating cash flow during the last 5 years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • The Return On Assets of CLMT (-1.26%) is worse than 69.86% of its industry peers.
  • With a Return On Invested Capital value of 2.32%, CLMT is not doing good in the industry: 66.03% of the companies in the same industry are doing better.
  • The Average Return On Invested Capital over the past 3 years for CLMT is significantly below the industry average of 23.10%.
Industry RankSector Rank
ROA -1.26%
ROE N/A
ROIC 2.32%
ROA(3y)-2.53%
ROA(5y)-5.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.26%
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100

1.3 Margins

  • Looking at the Operating Margin, with a value of 1.31%, CLMT is doing worse than 70.33% of the companies in the same industry.
  • CLMT's Operating Margin has declined in the last couple of years.
  • CLMT has a Gross Margin of 5.94%. This is in the lower half of the industry: CLMT underperforms 74.64% of its industry peers.
  • CLMT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.31%
PM (TTM) N/A
GM 5.94%
OM growth 3Y-22.92%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.42%
GM growth 5Y-8.51%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CLMT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLMT is destroying value.
  • The number of shares outstanding for CLMT has been increased compared to 1 year ago.
  • CLMT has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CLMT is higher compared to a year ago.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.32, we must say that CLMT is in the distress zone and has some risk of bankruptcy.
  • CLMT has a Altman-Z score of 1.32. This is comparable to the rest of the industry: CLMT outperforms 46.89% of its industry peers.
  • The Debt to FCF ratio of CLMT is 42.45, which is on the high side as it means it would take CLMT, 42.45 years of fcf income to pay off all of its debts.
  • CLMT has a Debt to FCF ratio (42.45) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 42.45
Altman-Z 1.32
ROIC/WACC0.31
WACC7.55%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

  • CLMT has a Current Ratio of 1.02. This is a normal value and indicates that CLMT is financially healthy and should not expect problems in meeting its short term obligations.
  • CLMT has a Current ratio (1.02) which is in line with its industry peers.
  • A Quick Ratio of 0.56 indicates that CLMT may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.56, CLMT is not doing good in the industry: 74.16% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.56
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CLMT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 57.95% over the past year.
  • CLMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.37%.
  • Measured over the past years, CLMT shows a quite strong growth in Revenue. The Revenue has been growing by 12.77% on average per year.
EPS 1Y (TTM)57.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.51%
Revenue 1Y (TTM)-20.37%
Revenue growth 3Y-4.07%
Revenue growth 5Y12.77%
Sales Q2Q%9.38%

3.2 Future

  • Based on estimates for the next years, CLMT will show a very strong growth in Earnings Per Share. The EPS will grow by 35.80% on average per year.
  • Based on estimates for the next years, CLMT will show a small growth in Revenue. The Revenue will grow by 7.41% on average per year.
EPS Next Y21.89%
EPS Next 2Y39.29%
EPS Next 3Y47.98%
EPS Next 5Y35.8%
Revenue Next Year1.44%
Revenue Next 2Y4.24%
Revenue Next 3Y5.28%
Revenue Next 5Y7.41%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. CLMT Valuation Analysis

4.1 Price/Earnings Ratio

  • CLMT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CLMT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLMT is valued a bit more expensive than 66.51% of the companies in the same industry.
  • CLMT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 53.25
EV/EBITDA 26.07
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CLMT's earnings are expected to grow with 47.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.29%
EPS Next 3Y47.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLMT Dividend Analysis

5.1 Amount

  • No dividends for CLMT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLMT Fundamentals: All Metrics, Ratios and Statistics

CALUMET INC

NASDAQ:CLMT (4/7/2026, 9:26:27 PM)

Premarket: 33.4 -1.33 (-3.83%)

34.73

-0.99 (-2.77%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-27
Earnings (Next)05-07
Inst Owners52.91%
Inst Owner Change0%
Ins Owners2.93%
Ins Owner Change0.26%
Market Cap3.01B
Revenue(TTM)4.14B
Net Income(TTM)-33.80M
Analysts78.33
Price Target29.84 (-14.08%)
Short Float %8.01%
Short Ratio3.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)567.09%
Min EPS beat(2)-12.92%
Max EPS beat(2)1147.11%
EPS beat(4)1
Avg EPS beat(4)95.01%
Min EPS beat(4)-407.62%
Max EPS beat(4)1147.11%
EPS beat(8)4
Avg EPS beat(8)49.37%
EPS beat(12)6
Avg EPS beat(12)143.53%
EPS beat(16)6
Avg EPS beat(16)-326.04%
Revenue beat(2)1
Avg Revenue beat(2)-1.64%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.47%
Revenue beat(4)3
Avg Revenue beat(4)3.7%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)9.31%
Revenue beat(8)7
Avg Revenue beat(8)6.19%
Revenue beat(12)10
Avg Revenue beat(12)6.21%
Revenue beat(16)14
Avg Revenue beat(16)8.9%
PT rev (1m)12.5%
PT rev (3m)34.1%
EPS NQ rev (1m)-24.82%
EPS NQ rev (3m)37.14%
EPS NY rev (1m)0%
EPS NY rev (3m)33.42%
Revenue NQ rev (1m)-5.1%
Revenue NQ rev (3m)-3.43%
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)3.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.73
P/FCF 53.25
P/OCF 27.68
P/B N/A
P/tB N/A
EV/EBITDA 26.07
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.87
Fwd EYN/A
FCF(TTM)0.65
FCFY1.88%
OCF(TTM)1.25
OCFY3.61%
SpS47.67
BVpS-8.44
TBVpS-10.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.26%
ROE N/A
ROCE 2.93%
ROIC 2.32%
ROICexc 2.48%
ROICexgc 2.72%
OM 1.31%
PM (TTM) N/A
GM 5.94%
FCFM 1.37%
ROA(3y)-2.53%
ROA(5y)-5.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.26%
ROIC(5y)N/A
ROICexc(3y)5.34%
ROICexc(5y)N/A
ROICexgc(3y)6.05%
ROICexgc(5y)N/A
ROCE(3y)6.66%
ROCE(5y)N/A
ROICexgc growth 3Y-33.5%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.76%
ROICexc growth 5YN/A
OM growth 3Y-22.92%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.42%
GM growth 5Y-8.51%
F-Score4
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 42.45
Debt/EBITDA 10.23
Cap/Depr 35.15%
Cap/Sales 1.26%
Interest Coverage 0.31
Cash Conversion 53.65%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.56
Altman-Z 1.32
F-Score4
WACC7.55%
ROIC/WACC0.31
Cap/Depr(3y)90.59%
Cap/Depr(5y)178.84%
Cap/Sales(3y)3.2%
Cap/Sales(5y)4.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.51%
EPS Next Y21.89%
EPS Next 2Y39.29%
EPS Next 3Y47.98%
EPS Next 5Y35.8%
Revenue 1Y (TTM)-20.37%
Revenue growth 3Y-4.07%
Revenue growth 5Y12.77%
Sales Q2Q%9.38%
Revenue Next Year1.44%
Revenue Next 2Y4.24%
Revenue Next 3Y5.28%
Revenue Next 5Y7.41%
EBIT growth 1Y16.81%
EBIT growth 3Y-26.06%
EBIT growth 5YN/A
EBIT Next Year102.47%
EBIT Next 3Y52.12%
EBIT Next 5Y40.1%
FCF growth 1Y145.98%
FCF growth 3YN/A
FCF growth 5Y24.66%
OCF growth 1Y334.7%
OCF growth 3Y2.68%
OCF growth 5Y11.64%

CALUMET INC / CLMT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CALUMET INC (CLMT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLMT.


What is the valuation status for CLMT stock?

ChartMill assigns a valuation rating of 1 / 10 to CALUMET INC (CLMT). This can be considered as Overvalued.


What is the profitability of CLMT stock?

CALUMET INC (CLMT) has a profitability rating of 1 / 10.


What is the financial health of CALUMET INC (CLMT) stock?

The financial health rating of CALUMET INC (CLMT) is 1 / 10.